Ir al contenido principal
← Toda la financiación verificada
Nivel AUS

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

Food and Drug Administration

Inicia sesión y completa tu Funding Passport para ver si calificas — un veredicto transparente basado en reglas, no una caja negra.

Iniciar sesión

Sobre esta oportunidad

The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.

Documentos requeridos

La fuente oficial no indica documentos específicos aquí — confirme los requisitos antes de postular.

Fuente y trazabilidad de verificación

Primera obtención
20 de noviembre de 2026
Última verificación
20 de noviembre de 2026
Huella del contenido
87a49fcacd600b05…